Navigation Links
Mesothelioma Experts Focus on Promising Immunotherapy Drug in New Article, According to Surviving Mesothelioma
Date:12/8/2015

In the wake of the FDA approval of Keytruda (pembrolizumab) for non-small cell lung cancer, researchers in Toronto have released an overview of the drug and its potential for treating other cancers, including mesothelioma. Surviving Mesothelioma has just posted an article on the new report. Click here to read it now.

In October, Keytruda was approved to treat non-small cell lung cancer by targeting cancer cells expressing a protein called PD-1.

In an article in Future Oncology, Drs. Safiya Karim and Natasha Leighl with Toronto's Princess Margaret Cancer Center explore Keytruda's potential for treating other cancers, such as malignant pleural mesothelioma, that express the same protein.

“Pembrolizumab is a PD-1 inhibitor that has shown clinical activity in a variety of solid tumors,” note the researchers.

“Because there are so few viable treatment options for patients with mesothelioma, the mesothelioma community is naturally very excited about the future possibilities for Keytruda. We'll be following news of this drug closely,” says Alex Strauss, Surviving Mesothelioma’s Managing Editor.

To read more about the Canadian report and the results of mesothelioma clinical trials with Keytruda, see Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug, now available on the Surviving Mesothelioma website.

Karim, s and Leighl, N, “Pembrolizumab for the treatment of thoracic malignancies: current landscape and future directions”, December 3, 2015, Future Oncology, Epub ahead of print, http://www.futuremedicine.com/doi/abs/10.2217/fon.15.294

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at http://www.prweb.com/releases/2015/12/prweb13117614.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved


Related medicine news :

1. Mesothelioma Law Firm Baron & Budd Calls Attention to Veterans Suffering from Asbestos-Related Diseases
2. Baron & Budd Supports Encouraging New Development in Mesothelioma Treatment
3. Nanotechnology Shows Potential in Fighting Mesothelioma
4. The Meso Foundation Congratulates Representative Betty McCollum’s Efforts to Advance Mesothelioma Research
5. Mesothelioma Advocate Participates in DoD Cancer Research Peer-Review
6. Novel cancer vaccine holds promise against ovarian cancer, mesothelioma
7. Penn mesothelioma program receives $8 million NCI grant
8. New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma
9. New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma
10. Study Warns of Kidney Damage Risk with Popular Mesothelioma Drug, Reports Surviving Mesothelioma
11. New Mesothelioma Research Website Offers In-Depth Articles About Technology and Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2018)... ... , ... With a petition (case CJ-2018-04177) filed last week in Tulsa County ... of lawsuits filed in states around the country against Massage Envy that seek to ... Envy’s massage therapists. , This lawsuit alleges that the company's corporate policies and ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... its mission to provide simple, easy-to-use software for biopharma companies. By pairing the ... quickly answer those crucial resourcing questions without spending millions of dollars implementing a ...
(Date:10/16/2018)... , ... October 16, 2018 , ... ... 2018 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th Annual FDA Inspections ... Inspections Summit that it sometimes feels difficult to keep up. The FDA is ...
(Date:10/16/2018)... ... October 15, 2018 , ... ... Body Fluids, Order Number 205bf, for easier linearity and calibration verification. , ... of linearity, calibration verification and verification of the reportable range for Albumin (ALB), ...
(Date:10/16/2018)... , ... October 16, 2018 , ... ... that it will host the proceedings of the 4th Annual International HPV Vaccine ... symposium that runs Wednesday, May 22, 2019, through Friday, May 24, 2019, with ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... ... October 16, 2018 , ... With suicide as the tenth leading cause of ... Psychiatric Nurses Association (APNA) has released a new training to equip nurses working in ... suicide in hospital settings are preventable, a recent survey of 15,000 health and behavioral ...
(Date:10/13/2018)... ... October 12, 2018 , ... David Young was ... was used in the Lockheed F22 Aircraft. Today, he announces the invention of ... which can lead to sudden cardiac death (SCD). , The Two-Dimensional Arrhythmia Monitor ...
(Date:10/11/2018)... ... , ... Alice* is artistic, intelligent and on her third school placement. Her parents remember that ... the bed covers, often waking up in a pool of sweat with terrifying nightmares that ... about everything, howled when she was separated from her parents and often demanded to sleep ...
Breaking Medicine Technology: